Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome

Internal Medicine

Volumn 46, Issue 6, 2007, Pages 311-313

  Kanai, Kazuaki ^a   Kuwabara, Satoshi ^a   Misawa, Sonoko ^a   Hattori, Takamichi ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Bevacizumab; Crow Fukase syndrome; POEMS syndrome; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; MELPHALAN; PREDNISOLONE; VASCULOTROPIN;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; DRUG INDICATION; FATALITY; FEMALE; HUMAN; PARAPROTEINEMIA; PLASMACYTOMA; PLEURA EFFUSION; PNEUMONIA; POLYNEUROPATHY; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RESPIRATORY FAILURE; TREATMENT DURATION;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FATAL OUTCOME; FEMALE; HUMANS; POEMS SYNDROME; TREATMENT FAILURE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33947613716     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6246     Document Type: Article

References (6)

1. Bardwick PA, Zvaifler NJ, Newman GD, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes: the POEMS syndrome. Report of two cases and a review of the literature. Medicine 59: 311-322, 1980.
2. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama K. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347: 702, 1996.
3. Kuwabara S, Misawa S, Kanai K, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 66: 105-107, 2006.
4. Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood 106: 1135, 2005.
5. Straume O, Bergheim J, Ernst P, Badros AZ, Jaccard A. Bevacizumab therapy for POEMS syndrome. Blood 107: 4972-4974, 2006.
6. Nagy JA, Senger DR. VEGF-A, cytoskeletal dynamics, and the pathological vascular phenotype. Exp Cell Res 312: 538-548, 2006.